Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Neoplasms × Triiodothyronine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Prostatic Neoplasms 1 Neoplasms 1

Interventions

Gemcitabine 29 pembrolizumab 22 Cyclophosphamide 20 Paclitaxel 17 Irinotecan 17 Carboplatin 17 Fluorouracil 16 Docetaxel 16 Capecitabine 16 Leucovorin 13 fludarabine 12 Bevacizumab 12 Oxaliplatin 11 Everolimus 11 Dexamethasone 11 Pemetrexed 10 Erlotinib Hydrochloride 10 Rituximab 9 Cisplatin 9 Blood Specimen Collection 9 venetoclax 8 Cetuximab 8 Trastuzumab 7 Nivolumab 7 aldesleukin 6 Temozolomide 6 Sunitinib 6 Ipilimumab 6 Interleukin-2 6 Epoetin Alfa 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02785341 2016-05-27

APA2

Institut Paoli-Calmettes

Phase NA Terminated

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡